Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.
Sanders-van Wijk S, Muzzarelli S, Neuhaus M, Kiencke S, Maeder M, Estlinbaum W, Tobler D, Mayer K, Erne P, Pfisterer ME, Brunner-La Rocca HP; TIME-CHF investigators. Sanders-van Wijk S, et al. Among authors: erne p. Eur J Heart Fail. 2013 Aug;15(8):910-8. doi: 10.1093/eurjhf/hft079. Epub 2013 May 10. Eur J Heart Fail. 2013. PMID: 23666681 Free article. Clinical Trial.
N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators. Maeder MT, et al. Among authors: erne p. Eur J Heart Fail. 2013 Oct;15(10):1148-56. doi: 10.1093/eurjhf/hft076. Epub 2013 May 8. Eur J Heart Fail. 2013. PMID: 23657728 Free article. Clinical Trial.
Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP; TIME-CHF Investigators. Sanders-van Wijk S, et al. Among authors: erne p. Circ Heart Fail. 2014 Jan;7(1):131-9. doi: 10.1161/CIRCHEARTFAILURE.113.000527. Epub 2013 Dec 18. Circ Heart Fail. 2014. PMID: 24352403 Free article. Clinical Trial.
Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
Sanders-van Wijk S, van Asselt AD, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Vuillomenet A, Peter M, Pfisterer ME, Brunner-La Rocca HP; TIME-CHF Investigators. Sanders-van Wijk S, et al. Among authors: erne p. JACC Heart Fail. 2013 Feb;1(1):64-71. doi: 10.1016/j.jchf.2012.08.002. Epub 2013 Feb 4. JACC Heart Fail. 2013. PMID: 24621800 Free article. Clinical Trial.
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators. Pfisterer M, et al. Among authors: erne p. JAMA. 2009 Jan 28;301(4):383-92. doi: 10.1001/jama.2009.2. JAMA. 2009. PMID: 19176440 Clinical Trial.
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
Kaiser C, Kuster GM, Erne P, Amann W, Naegeli B, Osswald S, Buser P, Schläpfer H, Brett W, Zerkowski HR, Schindler C, Pfisterer M; TIME Investigators. Kaiser C, et al. Among authors: erne p. Eur Heart J. 2004 Jun;25(12):1036-42. doi: 10.1016/j.ehj.2004.02.033. Eur Heart J. 2004. PMID: 15191774 Free article. Clinical Trial.
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.
Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, Eeckhout E, Erne P, Estlinbaum W, Kuster G, Moccetti T, Naegeli B, Rickenbacher P; Trial of Invasive versus Medical therapy in Elderly patients (TIME) Investigators. Pfisterer M, et al. Among authors: erne p. JAMA. 2003 Mar 5;289(9):1117-23. doi: 10.1001/jama.289.9.1117. JAMA. 2003. PMID: 12622581 Clinical Trial.
Effect of a strategy of comprehensive vasodilation versus usual care on health-related quality of life among patients with acute heart failure.
Belkin M, Wussler D, Gualandro DM, Shrestha S, Strebel I, Goudev A, Maeder MT, Walter J, Flores D, Kozhuharov N, Lopez-Ayala P, Danier I, de Oliveira Junior MT, Kobza R, Rickli H, Breidthardt T, Erne P, Münzel T, Mueller C. Belkin M, et al. Among authors: erne p. ESC Heart Fail. 2021 Oct;8(5):4218-4227. doi: 10.1002/ehf2.13543. Epub 2021 Aug 6. ESC Heart Fail. 2021. PMID: 34355538 Free PMC article. Clinical Trial.
530 results